These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11287766)

  • 1. Serum crosslaps correlations with serum ICTP and urine DPD in hemodialyzed and peritoneally dialyzed patients.
    Małyszko J; Wołczyński S; Zbroch E; Brzósko S; Małyszko J; Myśliwiec M
    Nephron; 2001 Mar; 87(3):283-5. PubMed ID: 11287766
    [No Abstract]   [Full Text] [Related]  

  • 2. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
    Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
    Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of bone disease in multiple myeloma: a comparison between the resorption markers urinary deoxypyridinoline/creatinine (DPD) and serum ICTP, and an evaluation of the DPD/osteocalcin and ICTP/osteocalcin ratios.
    Carlson K; Larsson A; Simonsson B; Turesson I; Westin J; Ljunghall S
    Eur J Haematol; 1999 May; 62(5):300-6. PubMed ID: 10359057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
    Inaba M; Okuno S; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y
    Osteoporos Int; 2005 May; 16(5):517-25. PubMed ID: 15322741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum procollagen type I carboxyterminal propeptide in CAPD and hemodialysis patients.
    Gerakis A; Apostolou T; Bagiatoudi G; Tzouganatou A; Margellos V; Nikolopoulou N; Billis A
    Perit Dial Int; 1996; 16 Suppl 1():S309-11. PubMed ID: 8728213
    [No Abstract]   [Full Text] [Related]  

  • 9. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
    Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
    J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy: what do we have, what do we need?
    Ferreira A
    Nephrol Dial Transplant; 1998; 13 Suppl 3():29-32. PubMed ID: 9568817
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum and urinary pyridinium cross-links in patients with predialysis chronic renal failure].
    Kagebayashi Y; Samma S; Yoshida K; Ozono S; Motomiya Y; Hirao Y; Fujii Y; Kishimoto T; Dohi K; Okajima E
    Nihon Jinzo Gakkai Shi; 1996 Jun; 38(6):248-53. PubMed ID: 8752966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum crosslaps as bone resorption marker in peritoneal dialysis.
    Negri AL; Quiroga MA; Bravo M; Marino A; Fradinger E; Bogado CE; Zanchetta JR
    Perit Dial Int; 2002; 22(5):628-30. PubMed ID: 12455578
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bone metabolism as assessed with selected markers of bone turnover as well as densitometry analysis in patients after successful kidney transplantation].
    Giza D; Stompór T; Katra B; Sieradzki J; Sułowicz W
    Przegl Lek; 2001; 58(11):979-84. PubMed ID: 11987839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of biochemical indicators of bone turnover in patients on chronic dialysis and after kidney transplantation].
    Kusec V; Smalcelj R
    Acta Med Croatica; 2004; 58(1):51-7. PubMed ID: 15125394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Skeletal scintigraph and some bone turnover markers in the diagnosis of renal osteodystrophy in hemodialysis patients].
    Bednarek-Skublewska A; Chrapko B; Ksiazek A
    Pol Arch Med Wewn; 2003 Sep; 110(3):943-50. PubMed ID: 14699686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
    Cantor T; Sci B
    Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed.
    Ferreira MA
    Nephrol Dial Transplant; 2000; 15 Suppl 5():8-14. PubMed ID: 11073268
    [No Abstract]   [Full Text] [Related]  

  • 18. [Usefulness of osteocalcin and CrossLaps as markers of bone turnover in children with chronic renal failure].
    Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Nahaczewska W
    Pol Merkur Lekarski; 2002 Apr; 12(70):257-60. PubMed ID: 12089882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
    Okuno S; Inaba M; Kitatani K; Ishimura E; Yamakawa T; Nishizawa Y
    Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy.
    Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Szymańska A; Nahaczewska W
    Med Sci Monit; 2003 Jan; 9(1):CR19-23. PubMed ID: 12552245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.